207 related articles for article (PubMed ID: 33076721)
21. Efficacy and safety of aripiprazole augmentation of clozapine in schizophrenia: a systematic review and meta-analysis of randomized-controlled trials.
Srisurapanont M; Suttajit S; Maneeton N; Maneeton B
J Psychiatr Res; 2015 Mar; 62():38-47. PubMed ID: 25619176
[TBL] [Abstract][Full Text] [Related]
22. Cognitive-behaviour therapy and schizophrenia.
Wykes T
Evid Based Ment Health; 2014 Aug; 17(3):67-8. PubMed ID: 25043430
[TBL] [Abstract][Full Text] [Related]
23. Clozapine and paliperidone palmitate antipsychotic combination in treatment-resistant schizophrenia and other psychotic disorders: A retrospective 6-month mirror-image study.
Bioque M; Parellada E; García-Rizo C; Amoretti S; Fortea A; Oriolo G; Palau P; Boix-Quintana E; Safont G; Bernardo M
Eur Psychiatry; 2020 Jul; 63(1):e71. PubMed ID: 32669145
[TBL] [Abstract][Full Text] [Related]
24. Rates of treatment-resistant schizophrenia from first-episode cohorts: systematic review and meta-analysis.
Siskind D; Orr S; Sinha S; Yu O; Brijball B; Warren N; MacCabe JH; Smart SE; Kisely S
Br J Psychiatry; 2022 Mar; 220(3):115-120. PubMed ID: 35049446
[TBL] [Abstract][Full Text] [Related]
25. Association between depressive symptoms and cognitive-behavioural therapy receipt within a psychosis sample: a cross-sectional study.
Mason A; Irving J; Pritchard M; Sanyal J; Colling C; Chandran D; Stewart R
BMJ Open; 2022 May; 12(5):e051873. PubMed ID: 35537795
[TBL] [Abstract][Full Text] [Related]
26. Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis.
Samara MT; Dold M; Gianatsi M; Nikolakopoulou A; Helfer B; Salanti G; Leucht S
JAMA Psychiatry; 2016 Mar; 73(3):199-210. PubMed ID: 26842482
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of olanzapine in comparison with clozapine for treatment-resistant schizophrenia: evidence from a systematic review and meta-analyses.
Souza JS; Kayo M; Tassell I; Martins CB; Elkis H
CNS Spectr; 2013 Apr; 18(2):82-9. PubMed ID: 23253621
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of clozapine compared with other second-generation antipsychotic drugs in patients with treatment-resistant schizophrenia: protocol for a systematic review and individual patient data meta-analysis of randomised controlled trials.
Siafis S; Schneider-Thoma J; Hamza T; Bighelli I; Dong S; Hansen WP; Davis JM; Salanti G; Leucht S
BMJ Open; 2023 Feb; 13(2):e064504. PubMed ID: 36810167
[TBL] [Abstract][Full Text] [Related]
29. Adjunctive second-generation antipsychotics for specific symptom domains of schizophrenia resistant to clozapine: A meta-analysis.
Bartoli F; Crocamo C; Di Brita C; Esposito G; Tabacchi TI; Verrengia E; Clerici M; Carrà G
J Psychiatr Res; 2019 Jan; 108():24-33. PubMed ID: 30447508
[TBL] [Abstract][Full Text] [Related]
30. [Cognitive-behavioural therapy in early psychosis: an open study in a clinical setting].
Marois MJ; Gingras N; Provencher MD; Mérette C; Emond C; Bourbeau J; Jomphe V; Roy MA
Can J Psychiatry; 2011 Jan; 56(1):51-61. PubMed ID: 21324243
[TBL] [Abstract][Full Text] [Related]
31. Structural magnetic resonance imaging predictors of responsiveness to cognitive behaviour therapy in psychosis.
Premkumar P; Fannon D; Kuipers E; Peters ER; Anilkumar AP; Simmons A; Kumari V
Schizophr Res; 2009 Dec; 115(2-3):146-55. PubMed ID: 19734016
[TBL] [Abstract][Full Text] [Related]
32. Cognitive behavioral therapy (brief vs standard duration) for schizophrenia.
Naeem F; Farooq S; Kingdon D
Schizophr Bull; 2014 Sep; 40(5):958-9. PubMed ID: 25069655
[TBL] [Abstract][Full Text] [Related]
33. Clozapine versus typical neuroleptic medication for schizophrenia.
Wahlbeck K; Cheine M; Essali MA
Cochrane Database Syst Rev; 2000; (2):CD000059. PubMed ID: 10796289
[TBL] [Abstract][Full Text] [Related]
34. Augmentation strategies in partial responder and/or treatment-resistant schizophrenia patients treated with clozapine.
Muscatello MR; Bruno A; De Fazio P; Segura-Garcia C; Pandolfo G; Zoccali R
Expert Opin Pharmacother; 2014 Nov; 15(16):2329-45. PubMed ID: 25284216
[TBL] [Abstract][Full Text] [Related]
35. A systematic review and meta-analysis of the effect of clozapine on cognitive functions in patients with treatment-resistant schizophrenia.
Cheuk NKW; Tse W; Tsui HKH; Ma CF; Chun JSW; Chung AKK; Chan SKW
Schizophr Res; 2024 Jun; 268():205-222. PubMed ID: 37788946
[TBL] [Abstract][Full Text] [Related]
36. CE: Original Research: Cognitive Behavioral Therapy for Symptom Management in Treatment-Resistant Schizophrenia.
Ryan M; Sattenspiel D; Chianese A; Rice H
Am J Nurs; 2022 Aug; 122(8):24-33. PubMed ID: 35862601
[TBL] [Abstract][Full Text] [Related]
37. Treatment resistant schizophrenia - review and a call to action.
Lally J; Gaughran F
Ir J Psychol Med; 2019 Dec; 36(4):279-291. PubMed ID: 30477599
[TBL] [Abstract][Full Text] [Related]
38. Group cognitive behavioural therapy for Chinese patients with psychotic disorder: A feasibility controlled study.
Wong AWS; Ting KT; Chen EYH
Asian J Psychiatr; 2019 Jan; 39():157-164. PubMed ID: 30639991
[TBL] [Abstract][Full Text] [Related]
39. A systematic review and meta-analysis of the association between clozapine and norclozapine serum levels and peripheral adverse drug reactions.
Tan MSA; Honarparvar F; Falconer JR; Parekh HS; Pandey P; Siskind DJ
Psychopharmacology (Berl); 2021 Mar; 238(3):615-637. PubMed ID: 33410989
[TBL] [Abstract][Full Text] [Related]
40. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.
Lewis SW; Davies L; Jones PB; Barnes TR; Murray RM; Kerwin R; Taylor D; Hayhurst KP; Markwick A; Lloyd H; Dunn G
Health Technol Assess; 2006 May; 10(17):iii-iv, ix-xi, 1-165. PubMed ID: 16707074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
